Clinical Gastroenterology and Hepatology Clinical Gastroenterology and Hepatology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Barrett ’s Esophagus Risk Factors In Patients without Gastroesophageal Reflux: A Large Population-based Study
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 24, 2024 Category: Gastroenterology Authors: Bibek Saha, Anjul Verma, Ross Dierkhising, Rachel Canning, John B. Kisiel, Prasad G. Iyer Tags: Research Letter Source Type: research

Follow-up Colonoscopy for Detection of Missed Colorectal Cancer after Diverticulitis
Colonoscopy is often recommended following an episode of diverticulitis to exclude missed colorectal cancer (CRC). This is a controversial recommendation based on limited evidence. We estimated the prevalence and odds of CRC and advanced colorectal neoplasia on colonoscopy in patients with diverticulitis compared to CRC screening. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 24, 2024 Category: Gastroenterology Authors: Walker D. Redd, Jennifer L. Holub, Hazel B. Nichols, Robert S. Sandler, Anne F. Peery Source Type: research

Blue Notes
Immune-mediated inflammatory disorders (IMIDs) including inflammatory bowel disease (IBD), rheumatoid arthritis (RA), psoriasis/psoriatic arthritis (PSO), and ankylosing spondylitis (AS), are associated with increased risk of major adverse cardiovascular events (MACE). There is uncertainty regarding the cardiovascular safety of newer medications for IMIDs such as biologics and small molecules (anti-IL-23, anti-IL-12/23, anti-TNFs, and JAKi). This network meta-analysis pooled 40 studies (36 RCTs) that reported MACE (myocardial infarction, cerebrovascular accident, unstable angina, cardiovascular death, or heart failure) in ...
Source: Clinical Gastroenterology and Hepatology - April 23, 2024 Category: Gastroenterology Authors: Charles J. Kahi Tags: Blue Notes Source Type: research

Front Cover
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 23, 2024 Category: Gastroenterology Source Type: research

Editorial Board
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 23, 2024 Category: Gastroenterology Source Type: research

Table of Contents
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 23, 2024 Category: Gastroenterology Source Type: research

Elsewhere in the AGA Journals
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 23, 2024 Category: Gastroenterology Source Type: research

Longitudinal Follow-up of Fib-4 in Patients at Risk of MASLD Receiving Low-dose Methotrexate Treatment
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 23, 2024 Category: Gastroenterology Authors: Jing Cui, Vincent Di Martino, Daniel H. Solomon Tags: Research Letter Source Type: research

Centrally Distributed Adiposity as a Modifiable Risk Factor for Fecal Incontinence: U.S. Population-Based Analysis
Fecal incontinence (FI) is highly prevalent with substantial impacts on quality of life and healthcare utilization. The impact of obesity on FI remains unclear, with differing conclusions using BMI as risk factor. We aimed to determine the association between obesity and FI, and whether this relationship is dependent on the distribution of adiposity (waist circumference-to-height ratio, WHtR). (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 22, 2024 Category: Gastroenterology Authors: Brent Hiramoto, Ryan Flanagan, Mayssan Muftah, Eric D. Shah, Walter W. Chan Source Type: research

En bloc endoscopic submucosal dissection of a large laterally spreading tumor involving the papilla
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 17, 2024 Category: Gastroenterology Authors: Shuhan Yu, Yonggang Ding, Qide Zhang Tags: Images and Videos Source Type: research

Complexity of trials on pain management in acute pancreatitis: an ongoing challenge
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 15, 2024 Category: Gastroenterology Authors: Sivesh K. Kamarajah, Graeme MacLennan, Sanjay Pandanaboyana Tags: Letter to the Editor Source Type: research

The Role of Advanced Practice Providers in Modern Gastroenterology Practice
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 12, 2024 Category: Gastroenterology Authors: Sarah Enslin, Vivek Kaul Source Type: research

Factors affecting nonfunctioning small pancreatic neuroendocrine neoplasms and proposed new treatment strategies
Despite previously reported treatment strategies for nonfunctioning small ( ≤20 mm) pancreatic neuroendocrine neoplasms (pNENs), uncertainties persist. We aimed to evaluate the surgically resected cases nonfunctioning small pNENs (NF-spNENs) in a large Japanese cohort to elucidate an optimal treatment strategy for NF-spNENs. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 12, 2024 Category: Gastroenterology Authors: Susumu Hijioka, Daiki Yamashige, Minoru Esaki, Goro Honda, Ryota Higuchi, Toshihiko Masui, Yasuhiro Shimizu, Masayuki Ohtsuka, Yusuke Kumamoto, Akio Katanuma, Naoto Gotohda, Hirofumi Akita, Michiaki Unno, Itaru Endo, Yukihiro Yokoyama, Suguru Yamada, Ippe Source Type: research

One Year Outcomes Among Children Identified With Celiac Disease Through A Mass Screening Program
Celiac disease (CD) mass screening remains controversial in part because of a paucity of data to support its benefit. The Autoimmunity Screening for Kids (ASK) study is a mass screening study for pediatric CD and type 1 diabetes in Colorado. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 12, 2024 Category: Gastroenterology Authors: Marisa G. Stahl, Zhaoxing Pan, Monique Germone, Sadie Nagle, Pooja Mehta, Mary Shull, Isabel Griffith, Brianne Shuler, Edward Hoffenberg, Iman Taki, Cristy Geno-Rasmussen, Marian J. Rewers, Jill M. Norris, Edwin Liu, ASK Study Group Source Type: research

Phenotypes of MASLD-associated hepatocellular carcinoma
Hepatocellular carcinoma (HCC) typically develops as consequence of liver cirrhosis, but HCC epidemiology has evolved drastically in recent years. Metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis (MASH), has emerged as the most common chronic liver disease worldwide and a leading cause of HCC. A substantial proportion of MASLD-associated HCC (MASLD-HCC) can also develop in patients without cirrhosis. The specific pathways that trigger carcinogenesis in this context are not completely elucidated, and recommendations for HCC surveillance in MASLD pat...
Source: Clinical Gastroenterology and Hepatology - April 9, 2024 Category: Gastroenterology Authors: Jes ús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs. Tags: Narrative Reviews Source Type: research